Hydrocortisone is a corticosteroid active pharmaceutical ingredient (API) belonging to the glucocorticoid class. It is chemically identical to cortisol, a naturally occurring steroid hormone produced by the adrenal cortex.
Hydrocortisone is used in pharmaceutical manufacturing for oral, topical, ophthalmic and other preparations, depending on the specific dosage form and approved formulation. It has anti-inflammatory and immunosuppressive properties and is used in medicines designed to manage inflammatory and corticosteroid-responsive conditions.
Hydrocortisone is distinct from its ester and salt derivatives, including Hydrocortisone Acetate, Hydrocortisone Sodium Succinate, Hydrocortisone Butyrate and Hydrocortisone Valerate. These are separate pharmaceutical substances with different chemical identities and specifications.
Hydrocortisone acts through intracellular glucocorticoid receptors. After binding to these receptors, it influences gene expression and the production of inflammatory mediators. This reduces inflammatory responses and modulates immune activity.
Its pharmacological effects include anti-inflammatory, antiallergic and immunosuppressive activity.
Hydrocortisone is used as an API in the manufacture of various pharmaceutical formulations, including:
The specific grade, particle-size distribution and material characteristics should be selected according to the intended formulation and applicable product requirements.
Hydrocortisone USP contains not less than 97.0% and not more than 102.0% of C21H30O5, calculated on the dried basis.
Quality control includes identification, assay, specific rotation, loss on drying, residue on ignition and applicable organic impurity and residual-solvent testing. The current USP–NF monograph should be followed for the exact test methods and acceptance criteria.
The International Pharmacopoeia also specifies an assay range of 97.0–102.0%, calculated with reference to the dried substance. The analytical procedures and other requirements should be followed according to the selected pharmacopoeial standard.
Micronized Hydrocortisone may require additional particle-size controls for particular formulation applications. Particle-size requirements should be established separately and supported by a validated measurement method.
Hydrocortisone should be packed in suitable, tightly closed pharmaceutical-grade containers that protect the material from moisture, contamination and light exposure.
The International Pharmacopoeia recommends storage in a well-closed container protected from light. Actual storage conditions, packaging configuration and retest period should be based on the approved product specification and stability data.
Hydrocortisone is a pharmacologically active corticosteroid. It should be handled by trained personnel using suitable personal protective equipment and appropriate containment and dust-control procedures. Avoid unnecessary dust generation, inhalation and direct contact. Consult the applicable safety data sheet and workplace handling procedures.
1. What is Hydrocortisone?
Hydrocortisone is a glucocorticoid corticosteroid, also known as cortisol.
2. What is the CAS number of Hydrocortisone?
The CAS number is 50-23-7.
3. What is the molecular weight of Hydrocortisone?
Its molecular weight is 362.46 g/mol.
4. What is the USP assay requirement?
The USP monograph specifies 97.0–102.0%, calculated on the dried basis.
5. Is Hydrocortisone the same as Hydrocortisone Acetate?
No. Hydrocortisone Acetate is an ester derivative with a different molecular formula, molecular weight and CAS number.
6. What pharmaceutical formulations use Hydrocortisone?
It is used in oral, topical, ophthalmic and other formulations, depending on the approved product and intended application.
7. Is Hydrocortisone manufactured by Pfizer?
Manufacturer identity must be confirmed from the original manufacturer's label, batch COA or other authorized documentation. This product description does not establish Pfizer as the manufacturer.
For technical and commercial enquiries regarding Hydrocortisone API, request the current product specification, batch-specific COA, applicable USP compliance statement, analytical documentation, particle-size information where applicable and stability data from the supplier.
| Parameter | Specification |
|---|---|
| Appearance | White or almost white crystalline powder |
| Identification | IR and HPLC complaint |
| Assay (HPLC) | 97.0–102.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.3% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Slightly soluble in water |